Category: NPR

Some ‘Cheaper’ Health Plans Have Surprising Costs

Well-known insurers are selling new sorts of health plans outside the Affordable Care Act exchanges that may sound cheaper but aren’t necessarily. Some, for example, charge extra for common surgeries.

U.S. Cities Skeptical Of FDA Warnings Against Medicine Imports From Canadian Firm

Critics question claims by federal officials that CanaRX jeopardizes patient safety. Many U.S. companies, cities, counties and school districts rely on the firm to help employees get cheaper medicine.

How Much Is Today’s HIV Research Centered Around The Search For A Cure?

For the second time ever, a man’s HIV infection has been sent into remission. NPR’s Mary Louise Kelly talks with Rowena Johnston, director of research for the Foundation for AIDS Research.

Bone Marrow Transplant Renders Second Patient Free Of HIV

British doctors report the apparent eradication of HIV from a patient who was undergoing treatment for cancer. It’s only the second time this has been accomplished, despite many attempts.

Governments Struggle To Find A Way To Pay Retirement Pension Bills

There’s a growing fiscal crisis hitting cities, counties and states across the U.S. It’s all about generous retiree health benefits that historically haven’t been fully funded.

Texas Sharpens Aim At Surprise Medical Bills In Bipartisan Proposal

Legislation introduced in Texas this week would force the state’s health care providers and health insurers to mediate payment disputes before they send bills to patients.

Foes Of Trump’s Restrictions On Family Planning Clinics See Law On Their Side

In 1991, the Supreme Court upheld restrictions on family planning providers that are similar to rules proposed by the Trump Administration. But Trump critics say the legal landscape has changed.

Bill That Would Regulate Doctors’ Care Of Babies Who Survive Abortions Fails In Senate

The Senate failed to advance a bill that would regulate doctors’ care of babies who survive abortions. NPR’s Mary Louise Kelly talks with Washington Post reporter Mike DeBonis about the vote.

Leaders Of 7 Pharmaceutical Manufacturers Face Tough Questioning On Capitol Hill

The CEOs of seven U.S. drug makers testified before the Senate Finance Committee on their pricing practices.

Double-Booked Surgeons: Study Raises Safety Questions For High-Risk Patients

Most patients do fine, research suggests, when the lead surgeon steps away to begin another procedure. But patients who are older or have underlying medical conditions sometimes fare worse.